ArticleFrontiers in oncology2025
Case report series: Pembrolizumab and enfortumab vedotin in plasmacytoid urothelial carcinoma.
Susanna G Bowen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it